抗磷脂抗体在系统性红斑狼疮血栓形成中作用的研究进展  

Research progress on the role of antiphospholipid antibodies in systemic lupus erythematosus thrombosis

作　　者：周迪 郝飞 ZHOU Di;HAO Fei(Department of Dermatology,the Second Naval Hospital of Southern Theater Command,the Chinese People's Liberation Army,Sanya,Hainan 572008,China;Department of Dermatology and Plastic Surgery,the Third Affiliated Hospital of Chongqing Medical University,Chongqing 401120,China)

机构地区：[1]中国人民解放军南部战区海军第二医院皮肤科,海南三亚572008 [2]重庆医科大学附属第三医院皮肤美容整形中心,重庆401120

出　　处：《医药前沿》2025年第4期17-19,共3页Journal of Frontiers of Medicine

基　　金：战区海军部队卫生实用课题研究(WSSY002)。

摘　　要：系统性红斑狼疮(SLE)血栓形成与抗磷脂抗体(aPLs)阳性密切相关,aPLs检测对评价SLE血栓形成患者的长期预后和疾病活动性很有帮助。因此,本文综述近年来aPLs在SLE患者血栓形成中作用的研究进展,以期为我国SLE血栓形成患者的诊治提供参考依据和研究方向。Thrombosis in systemic lupus erythematosus(SLE)is closely related to the positive antiphospholipid antibodies(aPLs).The detection of aPLs is helpful to evaluate the long-term prognosis and disease activity of SLE patients with thrombosis.Therefore,this article reviews the research progress of the role of aPLs in thrombosis in SLE patients in recent years,in order to provide reference and research direction for the diagnosis and treatment of SLE patients with thrombosis in China.

关 键 词：系统性红斑狼疮 血栓形成 抗磷脂抗体 预后 疾病活动性 综述 

分 类 号：R593[医药卫生—内科学]